211 related articles for article (PubMed ID: 35776720)
1. Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
Nakai M; Suda G; Ogawa K; Yoshida S; Hosoda S; Kubo A; Tokuchi Y; Kitagataya T; Yamada R; Shigesawa T; Ohara M; Sho T; Morikawa K; Sakamoto N
PLoS One; 2022; 17(7):e0270786. PubMed ID: 35776720
[TBL] [Abstract][Full Text] [Related]
2. Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
Ishikawa T; Endo S; Imai M; Azumi M; Nozawa Y; Sano T; Iwanaga A; Honma T; Yoshida T
Intern Med; 2020; 59(20):2465-2469. PubMed ID: 33055469
[TBL] [Abstract][Full Text] [Related]
3. A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis.
Miwa T; Hanai T; Nishimura K; Maeda T; Tajirika S; Imai K; Suetsugu A; Takai K; Yamamoto M; Shimizu M
PLoS One; 2022; 17(11):e0277829. PubMed ID: 36449492
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rifaximin, a poorly absorbed rifamycin antimicrobial agent, for hepatic encephalopathy in Japanese patients.
Hiramine Y; Uto H; Mawatari S; Kanmura S; Imamura Y; Hiwaki T; Saishoji A; Kakihara A; Maenohara S; Tokushige K; Ido A
Hepatol Res; 2021 Apr; 51(4):445-460. PubMed ID: 33533150
[TBL] [Abstract][Full Text] [Related]
5. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
[TBL] [Abstract][Full Text] [Related]
6. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
[TBL] [Abstract][Full Text] [Related]
7. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.
Tatsumi R; Suii H; Yamaguchi M; Arakawa T; Nakajima T; Kuwata Y; Toyota J; Hige S
Intern Med; 2021 May; 60(10):1501-1507. PubMed ID: 33361677
[TBL] [Abstract][Full Text] [Related]
9. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.
Miwa T; Hanai T; Nishimura K; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Shimizu M
JPEN J Parenter Enteral Nutr; 2022 May; 46(4):858-866. PubMed ID: 34287991
[TBL] [Abstract][Full Text] [Related]
10. Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis.
Duong N; Reuter B; Saraireh H; Nadhem O; Acharya C; Fagan A; Hassouneh R; Bajaj JS
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e897-e901. PubMed ID: 33991690
[TBL] [Abstract][Full Text] [Related]
11. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
[TBL] [Abstract][Full Text] [Related]
12. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.
Liu A; Perumpail RB; Kumari R; Younossi ZM; Wong RJ; Ahmed A
World J Hepatol; 2015 Dec; 7(29):2871-9. PubMed ID: 26692331
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites.
Yokoyama K; Fukuda H; Yamauchi R; Higashi M; Miyayama T; Higashi T; Uchida Y; Shibata K; Tsuchiya N; Fukunaga A; Umeda K; Takata K; Tanaka T; Shakado S; Sakisaka S; Hirai F
Medicina (Kaunas); 2022 Sep; 58(9):. PubMed ID: 36143954
[TBL] [Abstract][Full Text] [Related]
14. Covert and Overt Hepatic Encephalopathy: Diagnosis and Management.
Patidar KR; Bajaj JS
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2048-61. PubMed ID: 26164219
[TBL] [Abstract][Full Text] [Related]
15. Management of hepatic encephalopathy in Germany: a survey among physicians.
Labenz C; Adarkwah CC; Wörns MA; Miehlke S; Hofmann WP; Buggisch P; Galle PR; Frieling T; Labenz J
Z Gastroenterol; 2020 Jan; 58(1):49-56. PubMed ID: 31931540
[TBL] [Abstract][Full Text] [Related]
16. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.
Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C
J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
[TBL] [Abstract][Full Text] [Related]
18. Impact of non-selective ß-blockers on hepatic encephalopathy in patients with liver cirrhosis.
Labenz C; Nagel M; Toenges G; Kuchen R; Schattenberg JM; Hilscher M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
Eur J Intern Med; 2020 Dec; 82():83-89. PubMed ID: 32873457
[TBL] [Abstract][Full Text] [Related]
19. Hepatic encephalopathy: how to test and treat.
Rahimi RS; Rockey DC
Curr Opin Gastroenterol; 2014 May; 30(3):265-71. PubMed ID: 24717765
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
Am J Gastroenterol; 2019 May; 114(5):764-770. PubMed ID: 30848730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
